Integra Lifesciences Holdings Stock Filter Stocks by Fundamentals
| IART Stock | USD 24.24 0.66 2.80% |
Integra LifeSciences Holdings fundamentals help investors to digest information that contributes to Integra LifeSciences' financial success or failures. It also enables traders to predict the movement of Integra Stock. The fundamental analysis module provides a way to measure Integra LifeSciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Integra LifeSciences stock.
Integra | Shares Owned by Institutions |
Integra LifeSciences ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Integra LifeSciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Integra LifeSciences' managers, analysts, and investors.Environmental | Governance | Social |
Integra LifeSciences Institutional Holders
Institutional Holdings refers to the ownership stake in Integra LifeSciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Integra LifeSciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Integra LifeSciences' value.| Shares | Capital Research Global Investors | 2024-09-30 | 1.3 M | Voloridge Investment Management, Llc | 2024-09-30 | 1.1 M | D. E. Shaw & Co Lp | 2024-09-30 | 1 M | Charles Schwab Investment Management Inc | 2024-09-30 | 944.3 K | Neuberger Berman Group Llc | 2024-06-30 | 828.5 K | Northern Trust Corp | 2024-09-30 | 812.3 K | Glenmede Trust Co Na | 2024-09-30 | 727.8 K | Lord, Abbett & Co Llc | 2024-09-30 | 713.3 K | Norges Bank | 2024-06-30 | 686.8 K | Blackrock Inc | 2024-06-30 | 11.3 M | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 11 M |
Integra Fundamentals
| Return On Equity | -0.0042 | ||||
| Return On Asset | 0.0302 | ||||
| Profit Margin | (0) % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 3.53 B | ||||
| Shares Outstanding | 77.16 M | ||||
| Shares Owned By Insiders | 3.21 % | ||||
| Shares Owned By Institutions | 93.27 % | ||||
| Number Of Shares Shorted | 5.18 M | ||||
| Price To Earning | 26.94 X | ||||
| Price To Book | 1.20 X | ||||
| Price To Sales | 1.16 X | ||||
| Revenue | 1.54 B | ||||
| Gross Profit | 982.03 M | ||||
| EBITDA | 383.57 M | ||||
| Net Income | 67.74 M | ||||
| Cash And Equivalents | 451.52 M | ||||
| Cash Per Share | 5.41 X | ||||
| Total Debt | 1.68 B | ||||
| Debt To Equity | 1.03 % | ||||
| Current Ratio | 3.85 X | ||||
| Book Value Per Share | 19.73 X | ||||
| Cash Flow From Operations | 139.96 M | ||||
| Short Ratio | 7.11 X | ||||
| Earnings Per Share | (0.09) X | ||||
| Price To Earnings To Growth | 0.79 X | ||||
| Target Price | 28.11 | ||||
| Number Of Employees | 3.95 K | ||||
| Beta | 1.08 | ||||
| Market Capitalization | 1.82 B | ||||
| Total Asset | 3.78 B | ||||
| Retained Earnings | 946.86 M | ||||
| Working Capital | 751.06 M | ||||
| Current Asset | 438.5 M | ||||
| Current Liabilities | 139.13 M | ||||
| Net Asset | 3.78 B |
About Integra LifeSciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Integra LifeSciences Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Integra LifeSciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Integra LifeSciences Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Integra Stock Analysis
When running Integra LifeSciences' price analysis, check to measure Integra LifeSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra LifeSciences is operating at the current time. Most of Integra LifeSciences' value examination focuses on studying past and present price action to predict the probability of Integra LifeSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integra LifeSciences' price. Additionally, you may evaluate how the addition of Integra LifeSciences to your portfolios can decrease your overall portfolio volatility.